Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $120,000 of BIOHAVEN LTD. lobbying was just disclosed

None

$120,000 of BIOHAVEN LTD. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocacy related to patients with rare diseases Advocacy related to patients with rare diseases Advocacy related to patients with rare diseases"

You can find more data on corporate lobbying on Quiver Quantitative.

BHVN Hedge Fund Activity

We have seen 144 institutional investors add shares of BHVN stock to their portfolio, and 87 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

BHVN Price Targets

Multiple analysts have issued price targets for $BHVN recently. We have seen 6 analysts offer price targets for $BHVN in the last 6 months, with a median target of $17.5.

Here are some recent targets:

  • Jason Gerberry from B of A Securities set a target price of $11.0 on 06/29/2026
  • Douglas Tsao from HC Wainwright & Co. set a target price of $10.0 on 05/26/2026
  • Terence Flynn from Morgan Stanley set a target price of $18.0 on 05/13/2026
  • Leonid Timashev from RBC Capital set a target price of $22.0 on 05/05/2026
  • Samantha Semenkow from Citigroup set a target price of $17.0 on 04/02/2026
  • Tyler Van Buren from TD Cowen set a target price of $30.0 on 03/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles